GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Net Interest Income (for Banks)

AngioLab (XKRX:251280) Net Interest Income (for Banks)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


AngioLab (XKRX:251280) Business Description

Industry
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.